Planchard D, Besse B, Groen HJM, Hashemi SMS, et al. Phase 2 study of dabrafenib plus trametinib in patients with BRAF V600E-mutant metastatic non-small cell lung cancer: Updated 5-year survival rates and genomic analysis. J Thorac Oncol 2021 Aug 26. pii: S1556-0864(21)02403.
PMID: 34455067